.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
UBS
Mallinckrodt
Baxter
US Army
Medtronic
Novartis
Cipla
Accenture
Healthtrust

Generated: July 26, 2017

DrugPatentWatch Database Preview

TRANDATE HCT Drug Profile

« Back to Dashboard

What is the patent landscape for Trandate Hct, and when can generic versions of Trandate Hct launch?

Trandate Hct is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in TRANDATE HCT is hydrochlorothiazide; labetalol hydrochloride. There are thirty-one drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; labetalol hydrochloride profile page.

Summary for Tradename: TRANDATE HCT

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list237
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRANDATE HCT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-001Apr 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-004Apr 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-002Apr 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-003Apr 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TRANDATE HCT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-003Apr 10, 1987► Subscribe► Subscribe
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-001Apr 10, 1987► Subscribe► Subscribe
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-002Apr 10, 1987► Subscribe► Subscribe
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-003Apr 10, 1987► Subscribe► Subscribe
Glaxosmithkline
TRANDATE HCT
hydrochlorothiazide; labetalol hydrochloride
TABLET;ORAL019174-002Apr 10, 1987► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
US Army
Baxter
Harvard Business School
Merck
Mallinckrodt
Deloitte
Boehringer Ingelheim
Teva
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot